![]() |
Volumn 91, Issue 3, 2001, Pages 613-621
|
High risk of infertility and long term gonadal damage in males treated with high dose cyclophosphamide for sarcoma during childhood
|
Author keywords
Cancer survivors; Childhood cancer; Cyclophosphamide; Hypogonadism; Infertility; Late effects
|
Indexed keywords
ALKYLATING AGENT;
CYCLOPHOSPHAMIDE;
DACTINOMYCIN;
DOXORUBICIN;
FOLLITROPIN;
GONADORELIN;
TESTOSTERONE;
VINCRISTINE;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
DRUG MEGADOSE;
ENDOCRINE FUNCTION;
GONADAL DISEASE;
HIGH RISK POPULATION;
HUMAN;
HYPOGONADISM;
INFERTILITY;
MALE;
PRIORITY JOURNAL;
SARCOMA;
SEMEN ANALYSIS;
SPERMATOZOON COUNT;
ADOLESCENT;
ADULT;
ANTINEOPLASTIC AGENTS, ALKYLATING;
CHILD;
CHILD, PRESCHOOL;
CYCLOPHOSPHAMIDE;
FOLLICLE STIMULATING HORMONE;
GENITALIA, MALE;
HUMANS;
INFERTILITY, MALE;
LUTEINIZING HORMONE;
MALE;
RISK FACTORS;
SARCOMA;
TESTOSTERONE;
|
EID: 0035253444
PISSN: 0008543X
EISSN: None
Source Type: Journal
DOI: 10.1002/1097-0142(20010201)91:3<613::AID-CNCR1042>3.0.CO;2-R Document Type: Article |
Times cited : (268)
|
References (33)
|